Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,650

Participants

Timeline

Start Date

June 13, 2025

Primary Completion Date

June 30, 2032

Study Completion Date

June 30, 2032

Conditions
Prevent Whooping CoughPrevent DiphtheriaPrevent Tetanus
Interventions
BIOLOGICAL

DTacP

Vaccinate 1 dose at 2 months, 4 months, 6 months, 18-24 months and 6 years of age respectively, with each injection dose being 0.5 ml;Injection;

BIOLOGICAL

DTaP

Vaccinate 1 dose at 2 months, 4 months, 6 months, 18-24 months and 6 years of age respectively, with each injection dose being 0.5 ml.Injection

BIOLOGICAL

DTacP-IPV/Hib

Administer 1 dose at 2 months, 4 months, 6 months and 18 months of age respectively, with each injection dose being 0.5 ml.Injection

Trial Locations (1)

663100

RECRUITING

Yanshan County Center for Disease Control and Prevention, Wenshan Zhuang and Miao Autonomous Prefecture

All Listed Sponsors
collaborator

Yunnan Provincial Center for Disease Control and Prevention

UNKNOWN

collaborator

Shaanxi Provincial Center for Disease Control and Prevention

OTHER

collaborator

Guizhou Provincial Center for Disease Control and Prevention

UNKNOWN

collaborator

Shandong Provincial Center for Disease Control and Prevention

UNKNOWN

lead

Changchun BCHT Biotechnology Co.

INDUSTRY

NCT07112144 - Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial | Biotech Hunter | Biotech Hunter